The Editorial Office has been made aware of potential issues surrounding the scientific validity of this paper, hence has issued an expression of concern to notify readers whilst the Editorial Office investigates.
. 2021 Feb 16;41(2):BSR-20171001_EOC. doi: 10.1042/BSR-20171001_EOC
Expression of concern: evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma
Collection date 2021 Feb 26.
Keywords: CD133, gastric carcinoma, methioninase, PEG-PLGA nanoparticles, pemetrexed, scFV
© 2021 The Author(s).
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
PMCID: PMC7886877 PMID: 33600569
This is an expression of concern about the following article: "Evaluation of METase-pemetrexed-loaded PEG–PLGA nanoparticles modified with anti-CD133–scFV for treatment of gastric carcinoma" in volume 38, BSR20171001.